MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.
MYND Life Sciences has raised $1.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2025.
MYND Life Sciences's investors include National Research Council of Canada Industrial Research Assistance Program.
MYND Life Sciences is headquartered in Kelowna, Canada.
MYND Life Sciences is a life sciences company focused on novel psychedelic drug development and pharmaceuticals.
MYND Life Sciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MYND Life Sciences — Funding & Investors." VCBacked, February 11, 2025, https://www.vcbacked.co/company/mynd-life-sciences. Accessed August 15, 2026.
VCBacked. (2025). MYND Life Sciences — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/mynd-life-sciences
{{cite web |title=MYND Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/mynd-life-sciences |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated